The balloon catheter market is anticipated to be hampered by the high cost of stenting and coronary angioplasty
During the projection period, the global balloon catheters market is estimated to develop at a CAGR of 10.20%. (2021-2028).
The balloon catheter is a fragile and flexible catheter with a balloon-like attachment at its tip. When the catheter is in place, this balloon can be expanded or deflated to enlarge or establish a pathway.
Balloon Catheters are typically used to treat heart-related disorders, particularly coronary artery disease caused by diabetes, high blood cholesterol, and high blood pressure.
Other uses for balloon catheters include renal denervation, cryoablation, drug delivery, perfusion, and atherectomy, among others. With the rise in cardiac diseases, balloon catheter use has steadily increased in the health care industry, and it has become an essential part of medical diagnostics and treatment.
Market Drivers and Restraints
The rising prevalence of cardiac illnesses, the growing elderly population, the growing desire for minimally invasive surgery, and increasing government initiatives such as advantageous reimbursement policies are all major drivers of the worldwide balloon catheter market.
The market is also projected to be driven by technological improvements and increased R&D. Furthermore, the patient population with end-stage renal disease, with the majority of these patients requiring catheter surgery, is expected to increase the usage of balloon catheters for therapy.
Every year, over 60,000 coronary artery bypass surgeries are conducted in India, according to the Coronary Artery Disease among Asian Indians (CADI) Research Foundation. Asian Indians make about a fifth of the world's population and have the highest incidence of coronary artery disease (CAD).
Due to an ageing population with diabetes and high blood cholesterol levels, the number of coronary artery bypass surgeries will continue to rise.
The balloon catheter market is anticipated to be hampered by the high cost of stenting and coronary angioplasty, the risk of infection and arterial collapse associated with balloon catheterization, and the availability of alternatives such as bypass surgery.
Market Segmentation
Ordinary balloon catheters, cutting balloon catheters, scoring balloon catheters, drug-eluting balloon catheters, and stent graft balloon catheters are the product types that make up the market.
In 2017, the drug-eluting balloon catheter category grew at the fastest rate because it is safe, provides the highest rate of restoration of normal blood flow when compared to other balloon catheters, and reduces the use of vessel implants (such as stents), which can induce vessel fracture.
The balloon catheters market can be divided into polyurethane, nylon, and other materials such as silicon, depending on the type of material used. Because of its tensile strength, hemocompatibility, and biocompatibility, polyurethane is the most preferred material for balloon catheter manufacture.
Other materials with a sufficient coefficient of friction, pressure ratings, and radial force that reduce vascular injury during insertion, such as terephthalate and silicone, will contribute to market expansion.
The market can be split by disease indication, such as coronary artery disease and peripheral vascular disease. The most frequent type of cardiac illness, according to the World Health Organization (WHO), is coronary artery disease (CAD).
Around 17.7 million individuals died from cardiovascular disease in 2015, with roughly 8.8 million of these fatalities owing to coronary artery disease (CAD), whereas peripheral artery disease (PAD) is expected to impact 202 million people worldwide.
Ambulatory surgery centres, hospitals, cardiac catheterization laboratories, and others make up the end-user market.
Comments
Post a Comment